Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 175 episode artwork

EPISODE · Jan 12, 2026 · 10 MIN

Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 175

from ACCP JOURNALS · host ACCP JOURNALS

Dr. Jason Yerke summarizes current evidence from clinical trials and comparative studies evaluating terlipressin continuous infusion versus intermittent bolus dosing strategies, with a focus on efficacy, safety, and operational considerations. Read the full-text manuscript: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70084.

Episode metadata supplied by the publisher feed · Published Jan 12, 2026

Embed this episode

Ready to play

Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 175

0:00 10:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of ACCP JOURNALS?

This episode is 10 minutes long.

When was this ACCP JOURNALS episode published?

This episode was published on January 12, 2026.

Can I download this ACCP JOURNALS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!